Rivus Pharmaceuticals

Rivus posts data to back up muscle-sparing obesity drug claims

Rivus has unveiled data on its phase 2 obesity win in HF patients. The results show that the med can help patients cut weight while they retain muscle.

James Waldron Sep 30, 2024 11:09am

weight loss scale weigh measure tape obesity overweight

Rivus’ phase 2 obesity-related heart failure trial hits endpoint

Aug 13, 2024 8:57am

Abbvie's president adds COO title—Chutes & Ladders

Jun 30, 2023 9:30am

Rivus raises $132M series B as metabolic pipeline heats up

Sep 22, 2022 10:41am

Rivus throws down liver fat data on quest to climb NASH mountain

Feb 9, 2022 9:27am